skip to content

Clinical Neurosciences

Welcome to the Department of Clinical Neurosciences. 

Our mission is to improve the lives of people with neurological disorders. 

We are embedded within Cambridge University Hospitals, allowing our research questions to stem from problems we have encountered in the clinic, and to directly address the needs of patients and families. We work in partnership with the Departments of Psychiatry, Genetics and Paediatrics, to improve Brain and Mind Health, through life, together.

We investigate the mechanisms of brain disease and injury, to devise new diagnostics and treatments, as well as using large data to improve the way we deliver current treatments. Our work has already led to new treatments in use world-wide.

Professor Alasdair Coles
Head of Department

 


 



Latest news

Powerful new MRI scans enable life-changing surgery in first for adults with epilepsy

25 March 2025

Scientists have developed a new technique that has enabled ultra-powerful magnetic resonance imaging (MRI) scanners to identify tiny differences in patients’ brains that cause treatment-resistant epilepsy. It has allowed doctors at Addenbrooke’s Hospital, Cambridge, to offer the patients surgery to cure their condition...

First global pituitary study gives patients voice on research

20 March 2025

155 patients, carers and healthcare professionals across 14 countries identified their top 10 questions for researchers. Researchers from Cambridge and London have completed a study that is a world first of its kind and gives patients an important voice on future priorities. It was led by Angelos Kolias, Consultant...

Prestigious MRC Fellowship awarded to revolutionize microglia metabolism research and find groundbreaking treatments for cognitive decline in multiple sclerosis

14 March 2025

Dr. Luca Peruzzotti-Jametti of the Department of Clinical Neurosciences, University of Cambridge, has been awarded a prestigious MRC Clinician Scientist Fellowship. This £2 million, five-year grant will fund research to fundamentally reshape our understanding of neuroinflammation and cognitive decline in conditions such as...